[go: up one dir, main page]

DK1403275T3 - Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf - Google Patents

Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Info

Publication number
DK1403275T3
DK1403275T3 DK03290485T DK03290485T DK1403275T3 DK 1403275 T3 DK1403275 T3 DK 1403275T3 DK 03290485 T DK03290485 T DK 03290485T DK 03290485 T DK03290485 T DK 03290485T DK 1403275 T3 DK1403275 T3 DK 1403275T3
Authority
DK
Denmark
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Application number
DK03290485T
Other languages
English (en)
Inventor
Thierry Dubuffet
Pascal Langlois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1403275T3 publication Critical patent/DK1403275T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK03290485T 2003-02-28 2003-02-28 Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf DK1403275T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03290485A EP1403275B1 (fr) 2003-02-28 2003-02-28 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (1)

Publication Number Publication Date
DK1403275T3 true DK1403275T3 (da) 2005-12-05

Family

ID=31970533

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03290485T DK1403275T3 (da) 2003-02-28 2003-02-28 Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Country Status (18)

Country Link
US (1) US7166633B2 (da)
EP (1) EP1403275B1 (da)
JP (1) JP4563372B2 (da)
CN (1) CN1326871C (da)
AR (1) AR043409A1 (da)
AT (1) ATE307139T1 (da)
AU (1) AU2004217599B2 (da)
DE (1) DE60301930T2 (da)
DK (1) DK1403275T3 (da)
EA (1) EA009066B1 (da)
ES (1) ES2250846T3 (da)
HK (1) HK1086281A1 (da)
MY (1) MY136989A (da)
NZ (1) NZ541424A (da)
PL (1) PL215131B1 (da)
SI (1) SI1403275T1 (da)
WO (1) WO2004078107A2 (da)
ZA (1) ZA200505781B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1403275T3 (da) * 2003-02-28 2005-12-05 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
JP2008525515A (ja) * 2004-12-28 2008-07-17 ディーエスエム アイピー アセッツ ビー．ブイ． 光学活性なインドリン−２−カルボン酸の調製方法
US10583331B2 (en) 2013-12-27 2020-03-10 Molten Corporation Skin body structure for ball
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55867B1 (en) * 1981-12-29 1991-02-14 Hoechst Ag New derivatives of bicyclic aminoacids,processes for their preparation,agents containing these compounds and their use,and new bicyclic aminoacids as intermediates and processes for their preparation
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril
CN100448675C (zh) * 2002-02-07 2009-01-07 株式会社理光 喷墨装置、压强调节机构及喷墨打印机
DK1403275T3 (da) * 2003-02-28 2005-12-05 Servier Lab Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Also Published As

Publication number Publication date
JP2006519177A (ja) 2006-08-24
PL377238A1 (pl) 2006-01-23
PL215131B1 (pl) 2013-10-31
HK1086281A1 (en) 2006-09-15
WO2004078107A2 (fr) 2004-09-16
US7166633B2 (en) 2007-01-23
CN1326871C (zh) 2007-07-18
ES2250846T3 (es) 2006-04-16
EP1403275A1 (fr) 2004-03-31
ZA200505781B (en) 2006-11-29
CN1753906A (zh) 2006-03-29
DE60301930T2 (de) 2006-07-27
JP4563372B2 (ja) 2010-10-13
SI1403275T1 (sl) 2006-02-28
AU2004217599B2 (en) 2009-07-30
DE60301930D1 (de) 2006-03-02
AU2004217599A1 (en) 2004-09-16
NZ541424A (en) 2008-03-28
AR043409A1 (es) 2005-07-27
EA200501258A1 (ru) 2006-04-28
US20060149081A1 (en) 2006-07-06
EP1403275B1 (fr) 2005-10-19
EA009066B1 (ru) 2007-10-26
MY136989A (en) 2008-12-31
WO2004078107A3 (fr) 2004-10-21
ATE307139T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
DK1268424T3 (da) Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte
HK1089187A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
EG26629A (en) A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts
HK1089188A1 (en) Novel method of synthesising perindopril and the pharmaceutically- acceptable salts thereof
HK1096409A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1096408A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
DK1371659T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
HK1095839A1 (en) Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
DK1614687T3 (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf
DK1321471T3 (da) Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf
DK1348684T3 (da) Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
DK1403275T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1367063T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
HK1096407A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
NO20050885L (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
DK1422236T3 (da) Syntesefremgangsmåde for perindopril og farmaceutisk acceptable salte heraf